Загрузка...
Contrast-enhanced ultrasound identifies early extrahepatic collateral contributing to residual hepatocellular tumor viability after transarterial chemoembolization
The mainstay of treatment for unresectable hepatocellular carcinoma is locoregional therapy including percutaneous ablation and transarterial chemo- and radioembolization. While monitoring for tumor response after transarterial chemoembolization is crucial, current imaging strategies are suboptimal....
Сохранить в:
| Опубликовано в: : | Radiol Case Rep |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5930180/ https://ncbi.nlm.nih.gov/pubmed/29721125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radcr.2018.04.001 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|